bFGF, which is overexpressed in many types of cancer, can trigger the formation of metastatic tumor phenotype by promoting the progression of tumor cells and increasing its angiogenic potential (Korc and Friesel, 2009; Akl et al., 2016). This evidence concerns the gene FGF2 and neoplasm.